Efficacy and Safety of Tolterodine and Pilocarpine in Patients with Overactive Bladder
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000281
Abstract: Purpose:We evaluated the efficacy and safety of a combination of 2 mg tolterodine and 9 mg pilocarpine, vs tolterodine monotherapy in patients with overactive bladder.Materials and Methods:We enrol... read more here.
Keywords: efficacy safety; patients overactive; tolterodine pilocarpine; overactive bladder ... See more keywords
Efficacy of novel β3‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Urology"
DOI: 10.1111/iju.13877
Abstract: To investigate the efficacy of vibegron on nocturia in patients with overactive bladder. read more here.
Keywords: patients overactive; overactive bladder; nocturia patients; efficacy ... See more keywords
Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists
Sign Up to like & getrecommendations! Published in 2024 at "Pharmaceuticals"
DOI: 10.3390/ph17010116
Abstract: Solifenacin, a selective muscarinic receptor antagonist, is one of the best-tolerated and most effective medicines that relieve storage symptoms in patients with an overactive bladder (OAB). However, the persistence of solifenacin in daily clinical practice… read more here.
Keywords: managed urologists; therapy; use; discontinuation ... See more keywords